Edit |   |
---|---|
Antigenic Specificity | CD140b, Human (Rinucumab biosimilar) |
Clone | Rinucumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD140b Recombinant Antibody. Rinucumab (REGN2176) is a monoclonal antibody designed for the treatment of neovascular age-related macular degeneration.[ This drug was developed by Regeneron Pharmaceuticals, Inc. |
Immunogen | n/a |
Other Names | Anti-CD140b Recombinant Antibody, Research Grade Rinucumab, Anti-Human CD140b Recombinant Antibody, REGN-2176, REGN-2176-3 (combination of aflibercept and ricunumab), REGN2176, Antibody Drug Analogues, Monoclonal Antibody, YR1389, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1569263-06-4 |
Catalog # | YR1389 |
Price | please inquire |
Order / More Info | CD140b, Human (Rinucumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |